ravulizumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial AUST R: 330566Active ingredients:
ravulizumab
Dosage form:
Injection, intravenous infusion
Sponsor:
Alexion Pharmaceuticals Australasia Pty Ltd
Phone:
1 800 788 189
|
From
08 Jan 2025
to
09 Jan 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
|